Cognitive impairment in patients with Parkinson's disease and optimization of its treatment

Authors

  • Zokirov M.M Fergana Medical Institute of Public Health Department of Internal Diseases №1 Assistant of the department
  • Mukhammadjonov O 3rd year student of the Faculty of Medicine

Keywords:

Parkinson's disease, Parkinson's syndrome, cognitive status, memantine hydrochloride

Abstract

Parkinson's disease is the most common neurodegenerative disease in the world, which requires a comprehensive study of this disease, as well as the prevention of its complications. The article discusses the impairment of the cognitive status of patients with Parkinson's disease using the MMSE and FAB test tests, as well as the effect of the drug memantine hydrochloride on the cognitive status.

Downloads

Published

2022-04-23

Issue

Vol. 7 (2022): ESH

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Cognitive impairment in patients with Parkinson’s disease and optimization of its treatment. (2022). Eurasian Scientific Herald, 7, 177-180. https://geniusjournals.org/index.php/esh/article/view/1119